rupatadina cinfa

Medicinal product

(Invented) name

rupatadina cinfa

Active substance (s)

Rupatadinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX28, Rupatadine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2023-11-24

Date of renewal

Documents

2036_rupatadina cinfa 10 mg tab_PŽ_2023-11-24.docx

2036_rupatadina cinfa 10 mg tab_PL_2023-11-24.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Rupatadinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112144	98259	1098259	lizdinė plokštelė	N20		Receptinis	LT/L/23/2036/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-11-24	Registruotas